Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Revenue (Tables)

v3.24.1.1.u2
Note 5 - Revenue (Tables)
3 Months Ended
Mar. 31, 2024
Notes Tables  
Disaggregation of Revenue [Table Text Block]
   

Three Months Ended March 31,

 
   

2024

   

2023

 

Sales of products, net:

               

Pharmacy prescription and other revenue, net of PBM fees

  $ 11,324     $ -  

e-Commerce revenue

    2,865       2,876  

Sub total

    14,189       2,876  

Revenues from services:

               

Pharmacy 340B contract revenue

    3,304       -  
                 

Revenues, net

  $ 17,493     $ 2,876